We are live on ! Find out more
CV

Counterweight Ventures Portfolio holdings

AUM $201M
1-Year Est. Return 35.56%
This Fund
S&P 500
This Quarter Est. Return
+18.98%
1 Year Est. Return
+35.56%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$201M
AUM Growth
+$22.4M
Cap. Flow
-$1.59M
Cap. Flow %
-0.79%
Top 10 Hldgs %
36.36%
Holding
81
New
1
Increased
2
Reduced
54
Closed
–

Top Buys

Rank Stock Value
1
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$3.2M
2
MU icon
Micron Technology
MU
+$333K
3
RY icon
Royal Bank of Canada
RY
+$135K

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$381K
2
AVGO icon
Broadcom
AVGO
+$375K
3
NVDA icon
NVIDIA
NVDA
+$303K
4
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$301K
5
AAPL icon
Apple
AAPL
+$253K

Sector Composition

Rank Sector Weight
1 Technology 19.8%
2 Financials 7.94%
3 Healthcare 6.55%
4 Industrials 6%
5 Consumer Discretionary 5.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VIS icon
51
Vanguard Industrials ETF
VIS
$8.1B
$1.09M 0.54%
3,025
– –
IBIT icon
52
iShares Bitcoin Trust
IBIT
$46.7B
$1.02M 0.51%
30,544
-420
-1% -$17.1K
UNH icon
53
UnitedHealth
UNH
$376B
$1.02M 0.51%
2,446
-132
-5% -$48.9K
IYK icon
54
iShares US Consumer Staples ETF
IYK
$1.4B
$967K 0.48%
13,313
-165
-1% -$11.8K
CVX icon
55
Chevron
CVX
$392B
$897K 0.45%
5,409
-418
-7% -$77.8K
RTX icon
56
RTX Corp
RTX
$290B
$723K 0.36%
3,810
– –
XOM icon
57
ExxonMobil
XOM
$644B
$657K 0.33%
4,804
– –
BCRX icon
58
BioCryst Pharmaceuticals
BCRX
$2.28B
$621K 0.31%
62,050
-33,334
-35% -$301K
EFAV icon
59
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.34B
$619K 0.31%
7,058
– –
IBM icon
60
IBM
IBM
$211B
$553K 0.28%
1,966
– –
ZBH icon
61
Zimmer Biomet
ZBH
$18.2B
$538K 0.27%
6,250
– –
MU icon
62
Micron Technology
MU
$930B
$513K 0.26%
+444
New +$333K
MPC icon
63
Marathon Petroleum
MPC
$92.4B
$482K 0.24%
1,887
-340
-15% -$83.5K
LMT icon
64
Lockheed Martin
LMT
$134B
$463K 0.23%
908
-15
-2% -$8.11K
NEE icon
65
NextEra Energy
NEE
$181B
$435K 0.22%
4,957
– –
JNJ icon
66
Johnson & Johnson
JNJ
$618B
$418K 0.21%
1,646
– –
IYH icon
67
iShares US Healthcare ETF
IYH
$3.37B
$412K 0.21%
6,154
– –
OIH icon
68
VanEck Oil Services ETF
OIH
$2.06B
$389K 0.19%
1,045
– –
VZ icon
69
Verizon
VZ
$195B
$383K 0.19%
9,042
-2,692
-23% -$126K
MDY icon
70
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.6B
$367K 0.18%
522
– –
GOOGL icon
71
Alphabet (Google) Class A
GOOGL
$4.36T
$359K 0.18%
1,005
– –
QCOM icon
72
Qualcomm
QCOM
$155B
$349K 0.17%
1,888
– –
KIM icon
73
Kimco Realty
KIM
$17.2B
$348K 0.17%
13,728
– –
WMT icon
74
Walmart Inc
WMT
$885B
$326K 0.16%
2,882
– –
DWX icon
75
State Street SPDR S&P International Dividend ETF
DWX
$529M
$307K 0.15%
6,675
– –
1 2
3
4

Similar funds

FIA
FPC Investment Advisory Petaluma, California $201M AUM 10.58% 1-Year Est. Return
SA
Sycale Advisors New York $201M AUM 2.35% 1-Year Est. Return
LI
Latigo Investments Fort Lauderdale, Florida $201M AUM 18.61% 1-Year Est. Return
HC
Hara Capital Bellevue, Washington $200M AUM 49.32% 1-Year Est. Return
FFL
Financial Freedom LLC Cincinnati, Ohio $201M AUM 20.17% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $201M AUM 9.5% 1-Year Est. Return
SAM
Soviero Asset Management New York $200M AUM 134.59% 1-Year Est. Return
RCM
Ravenstone Capital Management Toronto $200M AUM 12.59% 1-Year Est. Return

Counterweight Ventures's Q2 2026 Portfolio in Review

As of Q2 2026, Counterweight Ventures held 81 positions worth $201M, up 13% from $178M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Trading was light in Q2 2026: portfolio turnover was 1.2%. Counterweight Ventures opened 1 new position and made no exits, leaving the 81-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Counterweight Ventures's largest Q2 2026 buy was Micron Technology: 444 shares worth $513K.
  • Counterweight Ventures added most to JPMorgan Ultra-Short Income ETF in Q2 2026, an estimated $3.2M increase.
  • Counterweight Ventures's biggest Q2 2026 reduction was Alphabet (Google) Class C, cutting an estimated $381K.
  • Counterweight Ventures's ten largest holdings make up 36% of its $201M portfolio in Q2 2026.
  • Counterweight Ventures opened 1 new position and closed 0 in Q2 2026.
  • Counterweight Ventures's portfolio value rose 13% quarter-over-quarter to $201M.

Based on Counterweight Ventures's 13F filing for Q2 2026, filed 23 Jul 2026.